Bravetti Clotilde, Le Garff-Tavernier Magali, De Septenville Anne, Maloum Karim, Toutée Adélaïde, Charlotte Frédéric, Lavaud Anne, Choquet Sylvain, Chapiro Élise, Maillon Agathe, Davi Frédéric, Costopoulos Myrto, Degaud Michaël
Service d'hématologie biologique, Hôpitaux universitaires Pitié-Salpêtrière-Charles-Foix, Paris, France.
Service d'ophtalmologie, Hôpitaux universitaires Pitié-Salpêtrière-Charles-Foix, Paris, France.
Ann Biol Clin (Paris). 2020 Oct 1;78(5):527-536. doi: 10.1684/abc.2020.1591.
We report the case of a man with a primary diagnosis of Waldenström macroglobulinemia. He secondarily presented a diffuse large B cell lymphoma (DLBCL) located in the nasal fossae, which relapsed later in the eye. The diagnosis of these two malignancies is based on a multidisciplinary biological approach using new sensitive and specific techniques. These techniques revealed that the two diseases harbor different B cell clones, indicating a distinct origin. This observation highlights the importance of targeted biological techniques for the diagnosis of these two rare hemopathies. It also shows that it is possible to prove the independent nature of the two tumor clones, thus allowing optimized therapeutic management.
我们报告了一例初步诊断为华氏巨球蛋白血症的男性病例。他继发于鼻腔的弥漫性大B细胞淋巴瘤(DLBCL),后来眼部复发。这两种恶性肿瘤的诊断基于使用新的敏感和特异技术的多学科生物学方法。这些技术显示这两种疾病含有不同的B细胞克隆,表明起源不同。这一观察结果突出了靶向生物学技术对这两种罕见血液病诊断的重要性。它还表明有可能证明两个肿瘤克隆的独立性,从而实现优化的治疗管理。